A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/18/2011	US20110201602 Protein kinase modulators and method of use
08/18/2011	US20110201601 Inhibitors of the shiga toxins trafficking through the retrograde pathway
08/18/2011	US20110201600 Chalcone linked pyrrolo[2,1-c][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
08/18/2011	US20110201599 CDK Modulators
08/18/2011	US20110201598 Pharmaceutical Compositions Comprising RET Inhibitors and Methods for the Treatment of Cancer
08/18/2011	US20110201597 Method and composition for treating alzheimer-type dementia
08/18/2011	US20110201596 Methods for Providing Oxidatively Stable Ophthalmic Compositions
08/18/2011	US20110201595 Oxazolidinyl antibiotics
08/18/2011	US20110201594 Pyrido [2,3-d] pyrimidines and their use as kinase inhibitors
08/18/2011	US20110201593 Tricyclic heterocyclic compounds, compositions and methods of use thereof
08/18/2011	US20110201592 Therapeutic Oxy-Phenyl-Aryl Compounds and Their Use
08/18/2011	US20110201591 Isonicotinamide orexin receptor antagonists
08/18/2011	US20110201590 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
08/18/2011	US20110201589 New bradykinin b1 antagonists
08/18/2011	US20110201587 Hsp90 inhibitors and methods of use
08/18/2011	US20110201586 Pharmaceutical composition and method for treating hypogonadism
08/18/2011	US20110201585 The Use of Oestrogen Applied to the Penis to Reduce HIV Infections
08/18/2011	US20110201584 Certain chemical entities, compositions, and methods
08/18/2011	US20110201583 Guanidine-containing compounds useful as muscarinic receptor antagonists
08/18/2011	US20110201582 Method and composition for treatment of skin conditions
08/18/2011	US20110201581 Novel Compounds 010
08/18/2011	US20110201580 Pyrrolidine derivatives
08/18/2011	US20110201579 Method of Improving the Overall Health of a Patient by Application of Pregnenolone
08/18/2011	US20110201578 Composition and methods for the treatment of pseudofolliculitis barbae and skin irritation
08/18/2011	US20110201577 Processes and intermediates for the preparation of oseltamivir and analogs thereof
08/18/2011	US20110201576 Small molecule inhibitors of stat3 with anti-tumor activity
08/18/2011	US20110201575 Stabilized solid dispersion of adefovir dipivoxil and preparation method thereof
08/18/2011	US20110201574 Fatty acid amide hydrolase inhibitors
08/18/2011	US20110201573 Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
08/18/2011	US20110201572 Pharmaceutical composition with glycosaminoglycans and use thereof in the treatment of chronic ulcers
08/18/2011	US20110201571 Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine
08/18/2011	US20110201570 Nucleus pulposus filler
08/18/2011	US20110201569 Methods For Treating Myocardial Disorders
08/18/2011	US20110201568 Phyotochemical composition and a process thereof
08/18/2011	US20110201567 Ivermectin Antagonizes Ethanol Inhibition in P2X4 Receptors
08/18/2011	US20110201566 Methods for treating resistant diseases using triazole containing macrolides
08/18/2011	US20110201565 Luteolin and diosmin/diosmetin as novel stat3 inhibitors for treating autism
08/18/2011	US20110201564 Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof
08/18/2011	US20110201563 Chimeric small molecules for the recruitment of antibodies to cancer cells
08/18/2011	US20110201560 Peptides for inhibiting the hpv-e6 oncoprotein
08/18/2011	US20110201558 Anaplerotic Therapy for Alzheimer's Disease and the Aging Brain
08/18/2011	US20110201555 Novel estrogen receptor ligands
08/18/2011	US20110201545 Gel based livestock feed, method of manufacture and use
08/18/2011	US20110201539 Detecting succinylacetone
08/18/2011	US20110201496 Substituted 5-Hetaryl-4-Aminopyrimidines
08/18/2011	US20110201029 Il-13 receptor antibodies
08/18/2011	US20110200695 Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue
08/18/2011	US20110200693 Increasing the efficiency of utilization of ingested creatine
08/18/2011	US20110200690 Compositions and methods for treating depression
08/18/2011	US20110200687 Bifeprunox mesylate maintenance dose compositions and methods for using the same
08/18/2011	US20110200686 Compositions of modulators of the wnt/b-catenin pathway and an n-cinnamyl-n'benzhydryl piperazine and their use in treating neoplastic conditions including malignant melanoma
08/18/2011	US20110200681 Abuse Resistant Drug Formulation
08/18/2011	US20110200678 Manufacturing method and apparatus of ultrafine particles having uniform particle size distribution
08/18/2011	US20110200677 Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer
08/18/2011	US20110200676 Cross-linked oxidated hyaluronic acid for use as a vitreous substitute
08/18/2011	US20110200675 Drug delivery vehicles, methods of manufacture, and methods of use thereof
08/18/2011	US20110200673 Oxidized heparin fractions and their use in inhibiting angiogenesis
08/18/2011	US20110200672 Coated tablet formulation and method
08/18/2011	US20110200671 Method of treating a disease condition susceptible to baclofen therapy
08/18/2011	US20110200670 Nicotine Containing Soft Gelatin Pastilles
08/18/2011	US20110200669 Method and compositions of civamide to treat disease of the intestines
08/18/2011	US20110200668 Pharmaceutical composition for preventing dysbiosis associated with enteral administration of antibiotics
08/18/2011	US20110200667 Veterinary pharmaceutical formulacion that comprises an rna recombinant particle that encodes for a cu/zn superoxide dismutase protein of ruminant pathogenic bacteria and at least one rna alphavirus belonging to the semliki forest virus family
08/18/2011	US20110200665 Novel Thermosensitive Liposomes Containing Therapeutic Agents
08/18/2011	US20110200663 Methylphenidate patch preparation
08/18/2011	US20110200662 Method For The Treatment Of Proliferative Disorders Of The Eye
08/18/2011	US20110200660 Poly(ester amide)-based drug delivery systems with controlled release rate and morphology
08/18/2011	US20110200649 Porous, Dissolvable Solid Substrate And Surface Resident Coating Comprising A Zync Pyrithione
08/18/2011	US20110200647 Pulmonary disease treatment
08/18/2011	US20110200646 The TRPVL Antagonists SB-795498 For Treating Rhinitis
08/18/2011	US20110200645 DHA Free Fatty Acid Emulsions
08/18/2011	US20110200644 DHA Ester Emulsions
08/18/2011	US20110200643 Emulsions for producing medicinal products
08/18/2011	US20110200626 Iqgap3 epitope peptides and vaccines containing the same
08/18/2011	US20110200625 Pharmaceutical composition
08/18/2011	US20110200621 Compositions and methods for treating cancer
08/18/2011	US20110200619 Pharmaceutical compounds as cytotoxic agents and uses thereof
08/18/2011	US20110200618 Erbb4 inhibitors and uses thereof in treatment of neuropsychiatric disorders
08/18/2011	US20110200603 New antigens for paratuberculosis diagnosis and vaccination
08/18/2011	US20110200597 Signal pathway alterations and drug target elevations in primary metachronous metastatic colorectal cancer compared to non-metastatic disease
08/18/2011	US20110200593 Combination Therapy for the Treatment of Ocular Neovascular Disorders
08/18/2011	US20110200588 Methods for genetic analysis
08/18/2011	US20110200587 Aminothiazolones as estrogen related receptor-alpha modulators
08/18/2011	US20110200586 Aminothiazolones as estrogen related receptor-alpha modulators
08/18/2011	US20110200583 Asthma Susceptibility Loci Located at Chromosome 1q31 for Use in Diagnostic and Therapeutic Methods
08/18/2011	US20110200582 Lipids, lipid compositions, and methods of using them
08/18/2011	US20110200581 Pharmaceutical compositions
08/18/2011	US20110200580 Methods of treatment and prevention of diet-induced obesity and sequelae thereof
08/18/2011	US20110200570 Composition and Method for Treating Infections and Promoting Intestinal Health
08/18/2011	US20110200564 Diagnosis and treatment of alzheimer's disease (ad)
08/18/2011	US20110200562 Chimeric Cytokine of IL-7 and Beta Chain of HGF and Methods of Use
08/18/2011	US20110200557 New 2-amidothiadiazole derivatives
08/18/2011	US20110200556 Chemoprevention of head and neck squamous cell carcinomas
08/18/2011	US20110200554 Therapeutic agent for hepatitis c
08/18/2011	US20110200553 Compounds and methods for the treatment or prevention of flavivirus infections
08/18/2011	US20110200544 Urea-based film-forming solution for treating nail psoriasis
08/18/2011	US20110200542 Skin cancer prevention method and product
08/18/2011	US20110200535 Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
08/18/2011	US20110200531 Treatment and diagnosis of central nervous system disorders
08/18/2011	US20110200527 Peptide Ligand Directed Drug Delivery

1 ... 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 ... 7860